Evidence map›Paper›PMID 34333846›Full record

ArticleJournal of thrombosis and haemostasis : JTH2021

The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark.

Eva Leinøe, Nanna Brøns, Andreas Ørslev Rasmussen, Migle Gabrielaite, Carlo Zaninetti, Raghavendra Palankar, Eva Zetterberg, Steen Rosthøj, Sisse Rye Ostrowski, Maria Rossing

Open access · hybridAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. AInternational journal of molecular sciences · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Eva LeinøeDepartment of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Nanna BrønsDepartment of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-9912-2806
Andreas Ørslev RasmussenCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Migle GabrielaiteCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Carlo ZaninettiDepartment of Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0003-1754-1260
Raghavendra PalankarDepartment of Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.
Eva ZetterbergCoagulation Unit, Skaane University Hospital, Malmø, Sweden.
Steen RosthøjDepartment of Pediatrics, Aalborg University Hospital, Aalborg, Denmark.
Sisse Rye OstrowskiDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Maria RossingCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-4325-3027
Copenhagen University Hospital · DKUniversitätsmedizin Greifswald · DEAalborg University Hospital · DKSkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe classic Bernard-Soulier syndrome (BSS) is a rare inherited thrombocytopenia (IT) associated with severe thrombocytopenia, giant platelets, and bleeding tendency caused by homozygous or compound heterozygous variants in GP1BA, GP1BB, or GP9. Monoallelic BSS (mBSS) associated with mild asymptomatic macrothrombocytopenia caused by heterozygous variants in GP1BA or GP1BB may be a frequent cause of mild IT.

objectiveWe aimed to examine the frequency of mBSS in a consecutive cohort of patients with IT and to characterize the geno- and phenotype of mBSS probands and their family members. Additionally, we set out to examine if thrombopoietin (TPO) levels differ in mBSS patients. PATIENTS/

methodsWe screened 106 patients suspected of IT using whole exome- or whole genome sequencing and performed co-segregation analyses of mBSS families. All probands and family members were phenotypically characterized. Founder mutation analysis was carried out by certifying that the probands were unrelated and the region around the variant was shared by all patients. TPO was measured by solid phase sandwich ELISA.

resultsWe diagnosed 14 patients (13%) with mBSS associated with heterozygous variants in GP1BA and GP1BB. Six unrelated probands carried a heterozygous variant in GP1BA (c.58T>G, p.Cys20Gly) and shared a 2.0 Mb region on chromosome 17, confirming that it is a founder variant. No discrepancy of TPO levels between mBSS patients and wild-type family members (P > .05) were identified.

conclusionWe conclude that the most frequent form of IT in Denmark is mBSS caused by the Copenhagen founder variant.

Indexed as

Bernard-Soulier SyndromeThrombocytopeniaDenmarkHomozygoteHumansPedigreePlatelet Glycoprotein GPIb-IX ComplexPlatelet Glycoprotein GPIb-IX ComplexBernard-Soulier syndromeDNApedigreesequence analysisthrombocytopeniathrombopoietin

Identifiers

PMID34333846
PMCPMC9292710
OpenAlexW3191038726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.